You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study

Article metrics

Article menu

Download PDFPDF

Heart failure and cardiomyopathies
Original research
Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study

 

Online download statistics by month:

Online download statistics by month: October 2020 to March 2024

AbstractFullPdf
Oct 2020440437118
Nov 202019619246
Dec 202017817542
Jan 202125024694
Feb 202123623565
Mar 202127126673
Apr 202125224851
May 202111911938
Jun 202112512232
Jul 202114314140
Aug 202111310930
Sep 202113412627
Oct 202115414968
Nov 20211059841
Dec 202114213943
Jan 2022969015
Feb 202216016345
Mar 202221320736
Apr 202222422625
May 202222122452
Jun 202222723534
Jul 202220820231
Aug 202217217559
Sep 202219920131
Oct 202222522827
Nov 202222723238
Dec 202214715621
Jan 202319520475
Feb 202323624028
Mar 202324924629
Apr 202314515028
May 202314615024
Jun 202321221741
Jul 202320220435
Aug 202315415925
Sep 202313213825
Oct 202312312725
Nov 202310310113
Dec 202377769
Jan 2024686810
Feb 2024575821
Mar 2024777480
Total735373531690